PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2012
SCMS is a multi-billion dollar PEPFAR Program managed by USAID and implemented by Partnership for Supply Chain Management (PfSCM). The purpose of SCMS is to ensure the supply of quality essential medicines and other products to people impacted by HIV/AIDS, and to promote sustainable supply chains in partner countries, in collaboration with US agencies and other stakeholders. SCMS supports the rapid scale up of HIV/AIDS prevention, care, and treatment through providing an uninterrupted supply of key commodities. As part of the USG strategy, the USG team is moving away from individual partner commodity procurement to this centralized mechanism. During FY 2012, only USAID will be putting money into this mechanism for its partners, but depending on the success of this procurement mechanism, CDC plans to program their commodities through this mechanism during COP 2013.
This is for the procurement of cotrimoxazole and limited therapeutic feeding supplements in USAID supported sites.
These funds will be used for the purcahse of TB-related test kits. Due to large pipeline issues, we gave USAID's main TB partner, TB2015, only minimal funding. These additional resources reflect the country's strategy of moving away from indvidual partner procurements for drugs to a centralized mechanism.
These funds will be used to purchase commodities for early infant diagnosis.
These funds will be used to purchase lab commodities for USAID supported sites.
The USG considers the use of and strengthening of FEDECAME as critical to long term sustainability and has the potential to lead to better drug availability, cost effectiveness, reduction of drug stock-outs, and ultimately to the improved health of the population. Under GHI, the USG will collaborate with other development partners to complement and not duplicate efforts. SCMS will work in partnership and collaboration with SIAPS to improve the supply management system within the DRC and will support the USG efforts to pilot direct procurement through the FEDECAME.
These funds will be used for mobile and facilities based counseling and testing commodities sites supported by USAID.
Most PMTCT commodities are budgeted with Acceleration Funding money ($3,410,000). This additional funding reflects the requirement that the DRC country team still needed to budget for PMTCT commodities in its normal budget.
These funds will be used for the purchase of ARVs for patients identifed through PMTCT, PITC, or Key Populations activities.